SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Advanced Enzyme Technologies informs about newspaper publication

21 Jun 2018 Evaluate

Pursuant to provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Advanced Enzyme Technologies has informed about submission of copy of the newspaper publication of 'Notice of Equity Shareholders of the Company, regarding transfer of Unclaimed Shares to IEPF Demat Account' published in The Free Press Journal and Navshakti on June 21, 2018.

The above information is a part of company’s filings submitted to BSE.

Advanced Enzyme Share Price

299.00 0.00 (0.00%)
21-Apr-2026 14:35 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1671.20
Dr. Reddys Lab 1220.40
Cipla 1233.30
Zydus Lifesciences 930.70
Lupin 2314.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×